Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. (Q50768129)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. |
scientific article published in March 2004 |
Statements
Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. (English)
1 reference
1 reference
1 reference
Roberta Rizzo
1 reference
Enrico Fainardi
1 reference
Loredana Melchiorri
1 reference
Vittorio Govoni
1 reference
Luisa Caniatti
1 reference
Ezio Paolino
1 reference
Maria Rosaria Tola
1 reference
Olavio Roberto Baricordi
1 reference
1 March 2004
1 reference
148
1 reference
1-2
1 reference
206-211
1 reference